Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing ...

Advisory Committee on Immunization Practice (ACIP) voted to expand its recommendation for the use of certain pneumococcal ...

Swedish Orphan Biovitrum, the Nordic biotech company also known as Sobi, today announced significantly improved financial ...

Sino-America clinical-stage biotech Eccogene announced that it will receive a $60 million payment from AstraZeneca, which is ...

Ocuphire Pharma has acquired Opus Genetics, creating a new entity focused on gene therapies, which will trade as Opus ...

Ipsen has reported strong Q3 2024 results, with sales reaching 837 million euros ($884 million), an 8.6% year-on-year ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved US pharma major Eli Lilly’s Kisunla (donanemab ...

Connecticut, USA-based Modifi Biosciences today announced that the company has been acquired by pharma giant Merck & Co (NYSE ...

US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was ...

Swiss pharma giant Roche this morning reported that, in the first nine months of 2024 group sales increased by 6% at CER (2% ...

Mumbai, India-based Mankind Pharma (NSE: MANKIND) has completed its acquisition of Bharat Serums and Vaccines (BSV), adding to its portfolio in the women’s health and fertility market. The 138 billion ...

The US Food and Drug Administration (FDA) yesterday approved Abrysvo (respiratory syncytial virus vaccine). Developed and ...